![Michael J. Cieslewicz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael J. Cieslewicz
Corporate Officer/Principal bei Vigeo Therapeutics, Inc.
Aktive Positionen von Michael J. Cieslewicz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Vigeo Therapeutics, Inc.
![]() Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vigeo Therapeutics, Inc. manufactures cancer drugs. It develops therapies designed to reprogram the tumor immune microenvironment by targeting CD36 and CD47 via Tsp-1 induction. The company was founded by Randolph Watnick and Jing Watnick in 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Karriereverlauf von Michael J. Cieslewicz
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Vigeo Therapeutics, Inc.
![]() Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vigeo Therapeutics, Inc. manufactures cancer drugs. It develops therapies designed to reprogram the tumor immune microenvironment by targeting CD36 and CD47 via Tsp-1 induction. The company was founded by Randolph Watnick and Jing Watnick in 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Michael J. Cieslewicz
- Erfahrung